Latest Smith+Nephew News & Updates

See the latest news and media coverage for Smith+Nephew. We track all announcements, press releases, and industry mentions in real time, all in one place.

Smith+Nephew

Portfolio medical technology company for tissue repair and replacement

smith-nephew.com

Headquarters: Watford, United Kingdom
Founded year: 1856
Company type: Public company
Number of employees: 15,000+
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about Smith+Nephew

In short: Smith+Nephew reported 2025 revenue growth of 6.1%, launched its new RISE strategy, and acquired Integrity Orthopaedics for up to $450m.

Company announcements

July 21 Smith+Nephew

Smith+Nephew expands ASC Solutions strategy

The strategy includes a new delivery model and partnerships to help ambulatory surgery centers improve performance.

May 22 Smith+Nephew

Smith+Nephew reports director's shareholding

A PDMR transaction has been disclosed in compliance with regulations.

May 6 Smith+Nephew

Smith+Nephew releases Q1 2026 trading report

It shows growth across all units and regions, innovation-driven growth, unchanged guidance, and $500 million share buyback.

April 28 Smith+Nephew

Smith+Nephew study shows faster recovery with REGENETEN implant

A randomized controlled trial found isolated bioinductive repair led to earlier return to activities and quality of life compared to traditional repair.

Media coverage

July 31 Barron's

Nano Dimension and 4 More Stocks See Action From Activist Investors

Activist investors report to the SEC on Nano Dimension, Smith & Nephew, Navigator Holdings, Global Net Lease, and Radcom.

July 29 Claim Depot

Smith & Nephew agrees to settle ERISA class action with cash payments to plan participants

Individuals who participated in the Smith & Nephew U.S. savings plan between Aug. 30, 2018, and May 13, 2026, may qualify to claim a payment...

July 29 Yahoo Finance

Smith+Nephew's TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been granted De Novo classification by the U.S. Food & Drug Administration (FDA...

July 28 GuruFocus

Smith & Nephew PLC (SNN) Stock Up 4.6% but GF Value Says Overval

On July 28, 2026, Smith & Nephew PLC (SNN) shares rose 4.6% to a current price of $32.56, reflecting...

Never miss news about Smith+Nephew

Track Smith+Nephew and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Smith+Nephew competitors & trending companies

Browse news for competitors to Smith+Nephew and other trending companies.